Piramal Pharma Limited's market cap is currently ₹271.17B. The company's EPS TTM is ₹-0.8; its P/E ratio is 273.22; and it has a dividend yield of 0.07%. Piramal Pharma Limited is scheduled to report earnings on July 28, 2025, and the estimated EPS forecast is ₹-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in INR
Piramal Pharma Limited Earnings and Revenue History
